Read More General business news Pharma Industry News Neuphoria Therapeutics secures milestone payment from Merck as Alzheimer’s clinical trial advances Neuphoria Therapeutics Inc. (Nasdaq: NEUP), a late-stage biotechnology company focused on developing treatments for neuropsychiatric disorders, has announced… byPallavi MadhirajuFebruary 12, 2025